Response of induced perturbation on replicating β-proteobacterial ammonia-oxidizing populations in soil

The short-term response of induced perturbation by 4-ethylphenol on β-proteobacterial ammonia oxidizers (β-AOB) was investigated in two soils with initial differences in community structure. The hypotheses were that short-term effects of a disturbance of the AOB community is best monitored by specifically looking at the active populations and that soils with dissimilar active AOB populations would display different degree of resistance or resilience. Two soils from a previously characterized long-term field study fertilized with manure or sewage sludge was used. Soil microcosms were incubated in the laboratory over 15 days. The substrate-induced ammonia oxidation was measured, and the composition of β-AOB communities was determined by PCR–DGGE of specific β-AOB 16S rRNA gene fragments. Actively replicating members of the β-AOB were distinguished by the use of bromodeoxyuridine (BrdU) immunocapture. This approach demonstrated that only a minor fraction of the total AOB community was active. Exposure to 4-ethylphenol resulted in approximately 90% lowered substrate-induced ammonia oxidation rates in both soils. This activity inhibition was not accompanied by shifts in β-AOB community structure when total β-AOB DNA was studied. By contrast, changes were seen in the DGGE banding pattern of the BrdU-labeled community DNA after 4-ethylphenol addition in the manure-fertilized soil. In the sewage sludge fertilized soil, the banding pattern of the BrdU-labeled β-AOB remained unchanged, but bands were weaker after the disturbance. In conclusion, it was shown that BrdU immunocapture was applicable to detect shifts in community composition among replicating β-AOB populations in soil. However, this was not reflected by the soils’ ammonia oxidation capacity to resist to or recover from the induced perturbation suggesting that rapid population shifts may not influence soil functioning in a short-term perspective.     

Extracellular Water and Blood Pressure in Adults with Growth Hormone (GH) Deficiency: A Genotype-Phenotype Association Study

Objectives

Growth hormone deficiency (GHD) in adults is associated with decreased extracellular water volume (ECW). In response to GH replacement therapy (GHRT), ECW increases and blood pressure (BP) reduces or remains unchanged. Our primary aim was to study the association between polymorphisms in genes related to renal tubular function with ECW and BP before and 1 year after GHRT. The ECW measures using bioimpedance analysis (BIA) and bioimpedance spectroscopy (BIS) were validated against a reference method, the sodium bromide dilution method (Br⁻).

Design and Methods

Using a candidate gene approach, fifteen single-nucleotide polymorphisms (SNPs) in nine genes with known impact on renal tubular function (AGT, SCNN1A, SCNN1G, SLC12A1, SLC12A3, KCNJ1, STK39, WNK1 and CASR) were genotyped and analyzed for associations with ECW and BP at baseline and with their changes after 1 year of GHRT in 311 adult GHD patients. ECW was measured with the Br⁻, BIA, and BIS.

Results

Both BIA and BIS measurements demonstrated similar ECW results as the reference method. At baseline, after adjustment for sex and BMI, SNP rs2291340 in the SLC12A1 gene was associated with ECW volume in GHD patients (p = 0.039). None of the SNPs influenced the ECW response to GHRT. One SNP in the SLC12A3 gene (rs11643718; p = 0.024) and three SNPs in the SCNN1G gene [rs5723 (p = 0.02), rs5729 (p = 0.016) and rs13331086 (p = 0.035)] were associated with the inter-individual differences in BP levels at baseline. A polymorphism in the calcium-sensing receptor (CASR) gene (rs1965357) was associated with changes in systolic BP after GHRT (p = 0.036). None of these associations remained statistically significant when corrected for multiple testing.

Conclusion

The BIA and BIS are as accurate as Br⁻ to measure ECW in GHD adults before and during GHRT. Our study provides the first evidence that individual polymorphisms may have clinically relevant effects on ECW and BP in GHD adults.     

Contribution of Adipose Triglyceride Lipase and Hormone-sensitive Lipase to Lipolysis in hMADS Adipocytes

Lipolysis is the catabolic pathway by which triglycerides are hydrolyzed into fatty acids. Adipose triglyceride lipase (ATGL) and hormone-sensitive lipase (HSL) have the capacity to hydrolyze in vitro the first ester bond of triglycerides, but their respective contributions to whole cell lipolysis in human adipocytes is unclear. Here, we have investigated the roles of HSL, ATGL, and its coactivator CGI-58 in basal and forskolin-stimulated lipolysis in a human white adipocyte model, the hMADS cells. The hMADS adipocytes express the various components of fatty acid metabolism and show lipolytic capacity similar to primary cultured adipocytes. We show that lipolysis and fatty acid esterification are tightly coupled except in conditions of stimulated lipolysis. Immunocytochemistry experiments revealed that acute forskolin treatment promotes HSL translocation from the cytosol to small lipid droplets and redistribution of ATGL from the cytosol and large lipid droplets to small lipid droplets, resulting in enriched colocalization of the two lipases. HSL or ATGL overexpression resulted in increased triglyceride-specific hydrolase capacity, but only ATGL overexpression increased whole cell lipolysis. HSL silencing had no effect on basal lipolysis and only partially reduced forskolin-stimulated lipolysis. Conversely, silencing of ATGL or CGI-58 significantly reduced basal lipolysis and essentially abolished forskolin-stimulated lipolysis. Altogether, these results suggest that ATGL/CGI-58 acts independently of HSL and precedes its action in the sequential hydrolysis of triglycerides in human hMADS adipocytes.Adipose tissue fat stores in humans are mainly dependent upon fatty acid (FA)² supply, FA esterification to triglycerides (TG), and TG breakdown, or lipolysis. Adipose tissue lipolysis is governed by three lipases. Adipose triglyceride lipase (ATGL) and hormone-sensitive lipase (HSL) both have the capacity to initiate TG degradation by cleaving the first ester bond, but HSL is unique in its capacity to break down the second ester bond, converting diglycerides (DG) to monoglycerides (1–3). The non-rate-limiting monoglyceride lipase completes lipolysis by cleaving the last ester bond from a monoglyceride molecule, leading to glycerol release (4). Adipose tissue lipolysis has received much attention over the past 10 years because of its altered regulation in obesity (5).HSL resides freely in the cytosol and can associate with lipid droplets (LD). It is regulated by hormones such as catecholamines, insulin, and natriuretic peptides. Catecholamines bind to β-adrenoceptors on adipocyte cell membranes and activate cyclic AMP-dependent protein kinase. Similarly, natriuretic peptides bind to type A receptors and activate cyclic GMP-dependent protein kinase (6). The protein kinase action in stimulated lipolysis is 2-fold: 1) phosphorylation of HSL, leading to its translocation from the cytosol to LD (7, 8), and 2) phosphorylation of perilipin A (6, 9, 10), the predominant perilipin isoform in adipocytes, enhancing interaction between HSL and LD. The importance of HSL activity in stimulating complete lipolysis is indisputable, particularly given its unique capacity to hydrolyze DG. However, lipolysis is not exclusively dependent upon HSL because HSL null mice revealed residual TG lipase activity in adipose tissue (2, 11). Another adipose tissue lipase was identified (3, 12, 13). ATGL, also known as desnutrin or patatin-like phospholipase domain-containing protein 2, shows affinity toward TG only (3, 14). ATGL is activated by CGI-58, an esterase/thioesterase/lipase subfamily protein devoid of TG hydrolase enzymatic activity (15, 16). The role of HSL and ATGL has been investigated in murine fat cell lipolysis, but the relative importance of these lipases in basal and protein kinase A-stimulated human fat cell lipolysis has remained elusive.Increased fat mass is associated with defects in adipose tissue metabolism. In obesity, resistance to catecholamine-induced lipolysis is observed (17–19). This inhibition of lipolysis may be naturally occurring as an adaptive protective mechanism to minimize FA release and its deleterious consequences on metabolism. Indeed, decreased expression of HSL and ATGL has been observed in isolated adipocytes and differentiated preadipocytes of obese subjects and adipose tissue of insulin-resistant subjects, respectively (20–23). However, by virtue of its mass, adipose tissue basal lipolysis elevates circulating levels of FAs in obese subjects, thereby increasing the risk of insulin resistance. Therefore, the use of pharmacological lipid-lowering agents that act through inhibition of lipolysis has been a promising research avenue leading to the development of several series of HSL inhibitors (24).Herein, we sought to examine the respective contributions of HSL and ATGL to lipolysis and re-esterification in fat cells derived from human adipose tissue derived-multipotent stem cells (termed hMADS cells). These cells, which exhibit at a clonal level normal karyotype, self-renewal ability, and no tumorigenicity, are able to differentiate into functional adipocytes (25, 26). We investigated the localization of HSL and ATGL in basal and stimulated lipolytic conditions and studied lipase activities and whole cell lipolysis in adipocytes with altered expression levels of HSL, ATGL, and its coactivator CGI-58. Our results provide novel insights into ATGL localization and its critical role with coactivator CGI-58 in DG provision to HSL during basal and stimulated lipolysis.     

Differential Effect of Helicobacter pylori Eradication on Time‐Trends in Brady/Hypokinesia and Rigidity in Idiopathic Parkinsonism

Background: We examine the effect of eradicating Helicobacter in idiopathic parkinsonism (IP). Marked deterioration, where eradication‐therapy failed, prompted an interim report in the first 20 probands to reach de‐blinding. The null‐hypothesis, “eradication has no effect on principal outcome, mean stride length at free‐walking speed,” was rejected. We report on study completion in all 30 who had commenced post‐treatment assessments. Methods: This is a randomized, placebo‐controlled, parallel‐group efficacy study of eradicating biopsy‐proven (culture and/or organism on histopathology) Helicobacter pylori infection on the time course of facets of IP, in probands taking no, or stable long‐t½, anti‐parkinsonian medication. Persistent infection at de‐blinding (scheduled 1‐year post‐treatment) led to open active eradication‐treatment. Results: Stride length improved (73 (95% CI 14–131) mm/year, p = .01) in favor of “successful” blinded active over placebo, irrespective of anti‐parkinsonian medication, and despite worsening upper limb flexor rigidity (237 (57–416) Nm × 10^?3/year, p = .01). This differential effect was echoed following open active, post‐placebo. Gait did not deteriorate in year 2 and 3 post‐eradication. Anti‐nuclear antibody was present in all four proven (two by molecular microbiology only) eradication failures. In the remainder, it marked poorer response during the year after eradication therapy, possibly indicating residual “low‐density” infection. We illustrate the importance of eradicating low‐density infection, detected only by molecular microbiology, in a proband not receiving anti‐parkinsonian medication. Stride length improved (424 (379–468) mm for 15 months post‐eradication, p = .001), correction of deficit continuing to 3.4 years. Flexor rigidity increased before hydrogen‐breath‐test positivity for small intestinal bacterial overgrowth (208 (28–388) Nm × 10^?3, p = .02), increased further during (171 (67–274), p = .001) (15–31 months), and decreased (136 (6–267), p = .04) after restoration of negativity (32–41 months). Conclusion: Helicobacter is an arbiter of progression, independent of infection‐load.     

Precautionary Defaults—A New Strategy for Chemical Risk Management

In order to give adequate support to risk managers, new risk assessment methods should be developed that are (1) scientifically sound, (2) simplified, and (3) suited for precautionary risk management. In this Perspective we propose that the notion of a precautionary default can be a useful tool in the development of such methods. A precautionary default is a cautious or pessimistic assumption that is used in the absence of adequate information and that should be replaced when such information is obtained. Furthermore, we point out some promising research areas for the development of such indicators, viz. connections between chemical characteristics such as persistence and effect parameters, monitoring of contaminants in polar regions, monitoring of contaminants in breast milk, application of results from (human) toxicology in ecotoxicology and vice versa, (eco)toxicological test systems that are sensitive to effects on reproduction, and the application of bioinformatic methods to complex data, both in genomic research and in ecotoxicology. We conclude that precautionary decision-making does not require less science, but to the contrary it requires more science and improved communication between scientists and risk managers.     

Weather variables as predictors of Sphagnum growth on a bog

When surrounded by growing Sphagnum the rhizomes of Scirpus cespitosus grow vertically upwards in pace with the Sphagnum . It was found that there is a considerable variation in rhizome growth between years and it is assumed that this variation is determined by variation in Sphagnum growth. The latter variation is assumed to be dependent on the weather. Simple and multiple regression analysis of rhizome growth on various weather variables gave the following results: (1) Moisture conditions are decisive for the growth. (2) The distribution in time of the moisture is more important than mean values from a certain period. (3) Although moisture in June and August of the current year was important, the moisture conditions of August of the previous year explained ca 60% of the variation. (4) A combination of the two variables Birot's wetness index in August of the previous year and the same index in current June gave r²= 0.80.     

Apparent latent heat of evaporation from clothing: attenuation and "heat pipe" effects.

Investigating claims that a clothed person's mass loss does not always represent their evaporative heat loss (EVAP), a thermal manikin study was performed measuring heat balance components in more detail than human studies would permit. Using clothing with different levels of vapor permeability and measuring heat losses from skin controlled at 34 degrees C in ambient temperatures of 10, 20, and 34 degrees C with constant vapor pressure (1 kPa), additional heat losses from wet skin compared with dry skin were analyzed. EVAP based on mass loss (E(mass)) measurement and direct measurement of the extra heat loss by the manikin due to wet skin (E(app)) were compared. A clear discrepancy was observed. E(mass) overestimated E(app) in warm environments, and both under and overestimations were observed in cool environments, depending on the clothing vapor permeability. At 34 degrees C, apparent latent heat (lambda(app)) of pure evaporative cooling was lower than the physical value (lambda; 2,430 J/g) and reduced with increasing vapor resistance up to 45%. At lower temperatures, lambda(app) increases due to additional skin heat loss via evaporation of moisture that condenses inside the clothing, analogous to a heat pipe. For impermeable clothing, lambda(app) even exceeds lambda by four times that value at 10 degrees C. These findings demonstrate that the traditional way of calculating evaporative heat loss of a clothed person can lead to substantial errors, especially for clothing with low permeability, which can be positive or negative, depending on the climate and clothing type. The model presented explains human subject data on EVAP that previously seemed contradictive.